West Michigan Advisors, LLC Bristol Myers Squibb CO Transaction History

West Michigan Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	BUY	$65.71 - $74.53 $11,302 - $12,819	172 Added 6.07%	3,007 $208,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $194,140 - $229,890	2,835 New	2,835 $203,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $53,666 - $59,105	-739 Reduced 12.68%	5,088 $392,000
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $307,277 - $368,452	-4,998 Reduced 46.17%	5,827 $426,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $580,544 - $676,779	10,825 New	10,825 $675,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of West Michigan Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on West Michigan Advisors, LLC with notifications on news.